Role of SGLT3 in diabetes-mediated increased renal sodium reabsorption

SGLT3 在糖尿病介导的肾钠重吸收增加中的作用

• 批准号: 8092580
• 负责人: NILOOFAR M TABATABAI
• 金额: $ 24.98万
• 依托单位: MEDICAL COLLEGE OF WISCONSIN
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-15 至 2015-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8092580
• 关键词: Affinity; Age; Agonist; Amino Acid Sequence; Amino Acid Sequence Homology; Animal Model; Animals; Antibodies; Apical; Binding; Blood Pressure; Brain; C57BL/6 Mouse; COS-7 Cell; Cadmium; Carrier Proteins; Cell Line; Cell membrane; Cells; Chronic; Colon; Confocal Microscopy; Custom; Data; Development; Diabetes Mellitus; Diabetic Nephropathy; Diabetic mouse; End stage renal failure; Epithelial Cells; Exposure to; Family; Family suidae; Fluorescence; Fluorescent Antibody Technique; Genes; Glucose; Glucose Transporter; Goals; Health; Human; Hyperglycemia; Hypertension; Immunoblotting; In Vitro; Intestines; Investigation; Ion Channel; Ions; Kidney; Knock-out; Knowledge; Malignant Epithelial Cell; Measures; Mediating; Mediator of activation protein; Membrane Protein Traffic; Messenger RNA; Microscopy; Modeling; Mouse Strains; Mus; Muscle Fibers; Na(+)-K(+)-Exchanging ATPase; Non-Insulin-Dependent Diabetes Mellitus; Oocytes; Ovary; Phlorhizin; Physiological Processes; Play; Property; Protein Isoforms; Proteins; Proximal Kidney Tubules; Rattus; Renal carcinoma; Research Design; Risk Factors; Role; Secondary to; Side; Small Intestines; Sodium; Sodium Chloride; Techniques; Testing; Time; Tissues; United States; Water; Xenopus laevis; Xenopus oocyte; absorption; base; design; diabetic; diabetic patient; glucose analog; glucose transport; glucose uptake; in vivo; kidney cell; knock-down; mouse model; non-diabetic; novel; public health relevance; response; small hairpin RNA; solute; sugar; uptake; young adult

DESCRIPTION (provided by applicant): Diabetic nephropathy is the leading cause of end-stage renal disease in the United States. Hyperglycemia has been recognized as a major risk factor in the development and progression of diabetic nephropathy. Hyperglycemia-induced increase in proximal tubule (PT) Na+ retention has been shown in diabetic patients and in animal models of diabetes. This enhanced Na+ reabsorption may play a role in the development of hypertension, which is an additional contributing factor in the development of diabetic nephropathy and the end stage renal disease. A role for a PT sodium-glucose cotransporter (SGLT) in hyperglycemia-induced increased sodium retention has been suggested but this transporter has not yet been identified. Kidney expresses SGLT1 and SGLT2 on the apical side of the PT cells. These proteins play crucial roles in sodium-dependent uptake of glucose from the glomerular filtrate. SGLT3 mRNA has been found in the human kidney carcinoma cells and in the pig kidney. When over-expressed in Xenopus oocytes, human SGLT3 did not transport glucose but in response to glucose, it mediated inward flux of sodium. Mouse has two genes encoding SGLT3a and 3b and we have shown that their mRNAs were expressed in the kidney and in the cultured kidney cells from mouse. We also showed while mRNA levels of SGLT3s in cultured mouse primary kidney cells exposed to cadmium were several folds higher than in their levels in untreated cells, the sodium-dependent uptake of glucose in Cd-treated cells had decreased supporting that SGLT3 is not a glucose transporter. Based on the above and additional preliminary studies with the potent agonist of SGLT3, deoxynojirimycin (DNJ), we hypothesize that kidney SGLT3 serves as a novel glucose-stimulated Na+ transporter in the PT that may play role in hyperglycemia-induced Na+ retention in diabetes. To test our hypothesis, we propose: (1) To localize the SGLT3 protein in human and mouse kidneys, (2) To determine the role of SGLT3 in glucose-mediated Na+ uptake in PT cells in vitro, (3) To determine the role of SGLT3 in hyperglycemia-mediated PT Na+ reabsorption in vivo. The proposed in vitro and in vivo studies are designed to investigate the role of SGLT3 as a novel glucose-stimulated Na+ transporter that may play role in the enhanced Na+ reabsorption in diabetes. PUBLIC HEALTH RELEVANCE: One of the major adverse health effects of diabetes is damage to the kidneys. Increased kidney salt reabsorption in diabetes may play a role in the development of high blood pressure, which in turn can cause damage to the kidneys. The mechanism of diabetes-induced increased salt reabsorption is not known. We have evidence that a novel sodium transporter may be a mediator. The goal of this study is to show that human kidneys express this protein and also to show that glucose stimulates sodium uptake by this transporter. This study is designed to identify the mechanism for the enhanced salt retention in diabetes.

描述（由申请人提供）：糖尿病肾病是美国终末期肾病的主要原因。高血糖已被认为是糖尿病肾病发生和进展的主要危险因素。在糖尿病患者和糖尿病动物模型中，高血糖引起的近端小管 (PT) Na+ 潴留增加。这种Na+重吸收的增强可能在高血压的发生中发挥作用，而高血压是糖尿病肾病和终末期肾病发生的另一个促成因素。 PT 钠-葡萄糖协同转运蛋白 (SGLT) 在高血糖引起的钠潴留增加中发挥着作用，但这种转运蛋白尚未得到证实。肾脏在 PT 细胞的顶端表达 SGLT1 和 SGLT2。这些蛋白质在肾小球滤液中葡萄糖的钠依赖性吸收中发挥着至关重要的作用。 SGLT3 mRNA 在人肾癌细胞和猪肾中被发现。当人类 SGLT3 在非洲爪蟾卵母细胞中过度表达时，它不会转运葡萄糖，但会响应葡萄糖而介导钠的内流。小鼠有两个编码 SGLT3a 和 3b 的基因，我们已经证明它们的 mRNA 在小鼠的肾脏和培养的肾细胞中表达。我们还发现，虽然暴露于镉的培养的小鼠原代肾细胞中 SGLT3 的 mRNA 水平比未处理的细胞中的水平高出几倍，但镉处理的细胞中钠依赖性葡萄糖的摄取有所减少，这支持了 SGLT3 不是葡萄糖运输者。基于上述和其他对 SGLT3 强效激动剂脱氧野尻霉素 (DNJ) 的初步研究，我们假设肾脏 SGLT3 作为 PT 中新型葡萄糖刺激的 Na+ 转运蛋白，可能在糖尿病中高血糖诱导的 Na+ 潴留中发挥作用。为了检验我们的假设，我们建议：(1) 在人和小鼠肾脏中定位 SGLT3 蛋白，(2) 确定 SGLT3 在体外 PT 细胞中葡萄糖介导的 Na+ 摄取中的作用，(3) 确定其作用SGLT3 在高血糖介导的体内 PT Na+ 重吸收中的作用。拟议的体外和体内研究旨在研究 SGLT3 作为一种新型葡萄糖刺激的 Na+ 转运蛋白的作用，该转运蛋白可能在糖尿病中增强 Na+ 重吸收中发挥作用。 公众健康相关性：糖尿病对健康的主要不利影响之一是对肾脏的损害。糖尿病患者肾脏盐重吸收的增加可能会导致高血压的发生，进而对肾脏造成损害。糖尿病引起盐重吸收增加的机制尚不清楚。我们有证据表明一种新型钠转运蛋白可能是一种介质。这项研究的目的是证明人类肾脏表达这种蛋白质，并证明葡萄糖会刺激这种转运蛋白对钠的吸收。本研究旨在确定糖尿病患者盐潴留增强的机制。